Low-Dose ATG/PTCy Plus Ivarmacitinib for aGVHD Prevention in Haplo-PBSCT From Parous Female Donors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Low-Dose ATG/PTCy Plus Ivarmacitinib for aGVHD Prevention in Haplo-PBSCT From Parous Female Donors	graft versus host disease, immune system disorder	Recruiting	Phase 2	2026-05-06		NCT07570745

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	141

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Shanghai General Hospital Affiliated to Shanghai Jiao Tong University	Shanghai	China	1

Clinical trials